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This report provides sound evidence that the small molecule pharmaceutical PLX5622,
a highly selective CSF-1R kinase inhibitor, crosses the blood–retina barrier and
suppresses microglia activity. Members of this class of drug are in advanced clinical
development stages and may represent a novel approach to modulate ocular
inflammatory processes.
Introduction
Colony-stimulating factor 1 receptor (CSF-1R)
inhibition results in effective elimination of brain
microglia.1 However, the effect of such treatment on
the retinal microglia has not been reported to our
knowledge. To this end, we performed in vivo imaging
of the retina in transgenic microglia reporter mice
(CX3CR1-GFPþ/) treated orally with PLX5622 for 7
days, a highly selective CSF-1R inhibitor.2 Using
scanning laser ophthalmoscopy, we found dramatically
reduced microglia counts in the mouse retina.
Methods
Heterozygous fractalkine receptor reporter mice
were bred by crossing homozygous CX3CR1-GFPþ/þ
male mice3 with wildtype Balb/c females. Two-month-
old heterozygous mice then were fed with chow
containing PLX5622 (1200 parts per million [ppm]
formulated in AIN-76A standard rodent diet; Re-
search Diets, Inc., New Brunswick, NJ) or identical
chow without this compound. Animals were housed
under temperature and humidity-controlled condi-
tions in individually ventilated cages with a 12-hour
light/12-hour dark cycle. This study was approved by
the local Animal Ethics Committee (Veterina¨rdienst
des Kantons Bern: BE 14/16) and conformed to the
ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
At baseline and 1 week after commencement of the
PLX5622 diet, the retinas of the mice were imaged
using confocal laser scanning ophthalmoscopy (Hei-
delberg Spectralis HRAþOCT; Heidelberg Engineering
GmbH, Heidelberg, Germany) after intraperitoneal
anesthesia with 1 mg/kg medetomidine (Dormitor 1
mg/mL; Provet AG, Lyssach, Switzerland) and 80 mg/
kg ketamine (Ketalar 50mg/mL; Parke-Davis, Zurich,
Switzerland). Some mice were killed to confirm
findings on whole-mounts and by fluorescence-activat-
ed cell sorting (FACS) of retinas.
Retinal whole-mounts were prepared as described
previously,4,5 and double-stained for fluorescence
immunohistochemistry, labeling microglia (rabbit
anti-iba1 diluted 1:200, Cat #019-19741; Wako Pure
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Chemical Industries Ltd., Osaka, Japan), and retinal
ganglion cells (goat anti-brn3a [C-20] diluted 1:500;
sc-31984; Santa Cruz Biotechnologies, Heidelberg,
Germany).
For FACS analysis, the two retinas of individual
mice were combined and analyzed as one sample to
ascertain a sufficient number of cells in the specimen
for cell sorting.6 Briefly, the retinas were dissociated
in 0.4 Wu¨nsch units/mL Liberase TM Grade (Roche,
Basel, Switzerland) in DPBS at 378C for 30 minutes.
Then, the samples were washed in DPBS and
resuspended in FACS buffer (100mM EDTA, 20%
FBS, 0.5% Na-Azide, in DPBS) for antibody staining.
DNAse I (0.01%; Roche) was present in all solutions.
Retinal microglia were identified using fluorescent-
labelled antibodies against CD45 (30-F11, #103116,
1:100) and CD11b (M1/70, #101212, 1:100) from
Biolegend (San Diego, CA). Samples were incubated
for 20 minues with antibodies and then analyzed with
a LSR II Cytometer System using the BD FACSDiva
software (BD Biosciences, Allschwil, Switzerland).
The FACS data were analyzed with the Flowjo Single
Cell Analysis Software V10 (TreeStar, Ashland, OR).
For retina in vivo imaging, the pupils were dilated
with tropicamide 0.5%/phenylephrine 2.5% eyedrops
(Hospital Pharmacy, Inselspital, Bern, Switzerland).
Hypromellose 20 mg/mL (Methocel 2%; OmniVision
AG, Neuhausen, Switzerland) was applied on the eyes
to avoid dry corneas. Images of the retina then were
obtained in the blue light (488 nm) fundus autofluo-
rescence mode (BAF) using a noncontact ultra-
widefield 1028 lens (Heidelberg Engineering GmbH).
For statistical analysis, the number of microglia in
the widefield BAF images was counted using ImageJ
(version 1.48v; provided in the public domain at http://
imagej.nih.gov by the National Institutes of Health,
Bethesda, MD). Briefly, images were exported as jpegs
andbackground subtractionwas performed (rollingball
radius 4.0). The files then were converted into 8-bit
images and a threshold was manually set before
counting the cells using the particle analyzer (particle
size 25 to ‘).7 The mean of the two eyes of each animal
was used for further calculations, and results are given
as mean 6 standard deviation. The paired or unpaired
Student’s t-test was used as appropriate. Confidence
intervals were 2-sided, and a P value of , 0.05 was
considered statistically significant.
Results
The number of retinal GFP-expressing cells per
widefield BAF image decreased dramatically by
92.2% (confidence interval [CI], 83.8–100; P ¼
0.0001, paired t-test; n ¼ 5) from 881 6 116 cells at
baseline to 70 6 28 cells after 1 week of PLX5622
treatment. The cells that still were present displayed
the characteristic morphology of quiescent microglia
with ramified processes (Fig. 1). Immunohistochem-
istry staining of retinal whole-mounts for ionized
calcium-binding adapter molecule 1 confirmed these
findings (Fig. 2). The effect of PLX5622 on retinal
microglia was further investigated in FACS analysis.
The retinal microglia phenotype is characterized by
low expression levels of CD45 and high CD11b
(CD45lowCD11bþ).8 Here too, a significant decrease
of the cell population exhibiting these characteristics
was seen (Fig. 3). On cursory evaluation of optical
coherence tomography scans in treated animals, no
changes of total retinal thickness or layer architecture
were found. Based on histologic studies, it has been
Figure 1. Ultra-widefield blue light fundus autofluorescence images at baseline (A) and after 1 week of CSF-1R kinase inhibitor
treatment (B) from a representative animal. The area outlined in (B) is magnified in (C) to highlight the ramified processes typical for
quiescent retinal microglia.
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reported previously that PLX5622 does not cause
overt loss of other retinal cells (Dharmarajan S, et al.
IOVS 2016;57:ARVO E-Abstract 2223), at least in the
short-term.
Discussion
In the retina, we found drastic changes of GFP
expression in microglia reporter mice during treat-
ment with PLX5622, an orally administered selective
CSF-1R kinase inhibitor. We have not specifically
investigated cell death, but previous work in the
central nervous system suggests that microglia are
subject to apoptosis.1,9 Alternatively, the observed
phenotypic changes might be caused solely by altered
protein expression. Recently, Guan et al.10 reported
upregulation of the fractalkine receptor gene in
microglia of the spinal cord dorsal horn after
intrathecal administration of CSF-1. Further investi-
gations are warranted, whereby noninvasive imaging
of the retina might be a helpful tool with high spatial
resolution, affording identification of individual cells
in vivo.
In conclusion, selective CSF-1R kinase inhibition
may be a promising new approach for targeted
modulation of ocular microglia and inflammatory
processes in the retina.
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Figure 2. Comparison between scanning laser ophthalmoscopy and retinal whole-mount. Blue light autofluorescence scanning laser
ophthalmoscopy (BAF) was performed in vivo at baseline (A) and 1 week after CSF-1R kinase inhibitor treatment (B). The retinal whole-
mount (C) was collected immediately after in vivo imaging and double-stained using fluorescence immunohistochemistry. Individual cells
visible in the BAF image (B) can be identified in the whole-mount (C) stained for calcium-binding adapter molecule 1 (iba1,
corresponding cells highlighted for better visibility). Only the area of the whole-mount captured in the BAF image (B) is shown (the
Supplementary Figure shows the unmodified whole-mount), and ganglion cells have been stained (brn3a) to highlight retinal vessels for
spatial orientation.
Figure 3. Evaluation of microglia depletion in the retinas of PLX5622 fed mice. Representative FACS contour plots and corresponding
bar graph of the cell populations with typical microglia phenotype (CD45lowCD11bþ) in controls and PLX5622 fed animals (PLX) 7 days
after the initiation of PLX5622 chow (n ¼ 2 per group; **P , 0.01, unpaired t-test).
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kinase inhibitor on retinal microglia revealed by in
vivo scanning laser ophthalmoscopy. Trans Vis Sci
Tech. 2017;6(2):10, doi:10.1167/tvst.6.2.10
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